Compare · ACON vs HUM
ACON vs HUM
Side-by-side comparison of Aclarion Inc. (ACON) and Humana Inc. (HUM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ACON and HUM operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $46.23B, about 8199.1x ACON ($5.6M).
- Over the past year, ACON is down 68.9% and HUM is up 44.3% - HUM leads by 113.2 points.
- HUM has been more active in the news (16 items in the past 4 weeks vs 4 for ACON).
- HUM has more recent analyst coverage (25 ratings vs 0 for ACON).
- Company
- Aclarion Inc.
- Humana Inc.
- Price
- $2.26-3.83%
- $385.07+4.91%
- Market cap
- $5.6M
- $46.23B
- 1M return
- -22.34%
- -3.25%
- 1Y return
- -68.87%
- +44.33%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 4
- 16
- Recent ratings
- 0
- 25
Aclarion Inc.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Latest ACON
- SEC Form 10-Q filed by Aclarion Inc.
- Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology
- Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026
- Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice
- SEC Form S-8 filed by Aclarion Inc.
- Aclarion Announces Texas Spine Care Center as New CLARITY Site
- Chief Strategy Officer Bond Ryan was granted 55,000 shares (SEC Form 4)
- Executive Chairman Thramann Jeffrey John was granted 100,000 shares (SEC Form 4)
- Chief Financial Officer Gould Gregory A was granted 50,000 shares (SEC Form 4)
- Director Sequira Amanda Mae was granted 20,000 shares (SEC Form 4)
Latest HUM
- Humana upgraded by Morgan Stanley with a new price target
- Humana Subsidiary iCare Selected for Family Care and Family Care Partnership Contracts Across Southeast Wisconsin
- Director Smith Paul John was granted 544 units of Humana Common (SEC Form 4)
- Director Crawford Frederick John was granted 544 units of Humana Common (SEC Form 4)
- Humana upgraded by Evercore ISI with a new price target
- Humana upgraded by Leerink Partners with a new price target
- Humana downgraded by Raymond James
- New insider Crawford Frederick John claimed ownership of 21 units of Humana Common (SEC Form 3)
- New insider Smith Paul John claimed no ownership of stock in the company (SEC Form 3)
- SEC Form 10-Q filed by Humana Inc.